Zebepra-L
Rabeprazole 20 mg Enteric Coated Pellets + Levosulpiride 75 mg (Sustained Release)
The combined synergy of a potent PPI and an approved GI regulator. Zebepra-L offers dual-action relief by addressing both acid suppression and gastrointestinal motility disorders.
Composition
Enquiry
Have a question or need more information? We're Here to help—just fill out the form below.
Indications
- Gastric Ulcer
- Duodenal Ulcer
- GERD
- Diabetic Gastroparesis
- Irritable Bowel Syndrome (IBS)
Rabeprazole
- Potent PPI that effectively blocks proton pumps
- Rabeprazole 20 mg is sufficient to block the maximum amount of proton pump
- Safe and effective for long-term maintenance therapy of reflux esophagitis
- Controls GI discomfort and ensures effective acid suppression
Highlight
Rabeprazole is a powerful PPI offering prolonged safety and effectiveness in controlling acid-related disorders. Ideal for long-term maintenance of reflux conditions.
Levosulpiride
- Acts as both a dopamine D2 receptor antagonist and serotonin 5-HT4 receptor agonist
- Accelerates gastric and gallbladder emptying
- Superior to domperidone and other prokinetics
- Effectively reduces symptoms of dyspepsia
Why it matters
Levosulpiride's dual mechanism makes it a superior prokinetic, offering effective relief for GI motility issues and functional dyspepsia.
Rabeprazole
Effective acid suppression and long-term safety for reflux-related conditions.
Levosulpiride
Accelerates gastric emptying and provides superior relief for dyspepsia and IBS.